Skip to main content
OpenTrials
Completed

NCT Number: NCT05742503

Progesterone Containing Contraceptive Methods on Endogenous Progesterone Level

The aim of this study is to assess the effect of different progesterone containing contraceptive methods on safety and endogenous progesterone level

Completed

Looking for future studies?

Notify Me

Key information

Age range

20 year–35 year

Sex eligibility

Female

Study type

Observational

Primary location

Ahmed Ossman

Tanta, El-Gharbia, 31527, Egypt

About this study

Progestogen-only' contraceptives are presented as injections, implants, oral formulations, hormone-releasing intrauterine methods and emergency contraceptives. These substances could be used by females who are breastfeeding or have other contraindications to estrogen treatment, including those who are immediately postpartum, have thalassemia, sickle-cell disease, gallbladder disease, or currently experiencing thrombo-embolic disorders, valvular heart disease, ischemic heart disease.

Intrauterine, injectable methods and contraceptive implants named as long-acting reversible contraceptives (LARC) are the more efficient reversible contraceptive approaches are highly effective, longer-acting contraceptive methods levels.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • 80 healthy fertile females
  • 20-35 years
  • With normal menstrual history
  • Had at least one offspring after spontaneous pregnancy

Exclusion criteria

  • Any disease affects uterus (uterine tumors fibroids, endometriosis, prolapse, or tuberculosis).
  • Ovarian tumors
  • submucous myoma
  • irregular menstrual cycle
  • past or family history of breast disease
  • Diabetic patients,
  • medication affecting reproductive or metabolic functions.
  • endometrial thickness <7 mm on the secretory transformation day
  • history of spontaneous abortions
  • history of embryo transfer failure on over three occasions
  • Patients had cortisol medications
  • patients who received radiological treatment

Treatment and study plan

Depo-Provera

Other

Injectable progesterone

Implanon

Other

Etonogestrel implant

Norgestrel

Other

Pill containing progesterone

Mirena

Other

Levonorgestrel-releasing intra-uterine drug (IUD)

Primary outcomes

  1. Assess the effect of different progesterone containing contraceptive methods on safety and endogenous progesterone level

    Time frame: Six mounths

    The effect of different progesterone containing contraceptive methods on safety and endogenous progesterone level will be recorded

Sponsors and collaborators

Lead sponsor

Tanta University

Other

Registry information

Official study title

Effects of Different Progesterone Containing Contraceptive Methods on Safety and Endogenous Progesterone Level

Important dates

Study start
2021
Primary completion
2022
Study completion
2022
First posted
Feb 24, 2023
Registry last updated
Feb 24, 2023

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.